Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 07, 2020

SELL
$7.01 - $10.96 $18,997 - $29,701
-2,710 Closed
0 $0
Q1 2020

May 04, 2020

BUY
$5.4 - $10.45 $1,976 - $3,824
366 Added 15.61%
2,710 $20,000
Q4 2019

Feb 04, 2020

BUY
$4.1 - $6.21 $2,205 - $3,340
538 Added 29.79%
2,344 $14,000
Q3 2019

Nov 12, 2019

BUY
$3.24 - $7.35 $5,851 - $13,274
1,806 New
1,806 $11,000

Others Institutions Holding SCPH

About scPharmaceuticals Inc.


  • Ticker SCPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 27,402,100
  • Market Cap $97M
  • Description
  • scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company's lead product candidate is FUROSCIX that consists of formulation of furosemide, which is delivered through an on-body infusor for treatment of congestion in patients with heart failure. Its product p...
More about SCPH
Track This Portfolio

Track Victory Capital Management Inc Portfolio

Follow Victory Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.